Bijo Mathew

7.4k total citations
244 papers, 5.8k citations indexed

About

Bijo Mathew is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Bijo Mathew has authored 244 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Organic Chemistry, 98 papers in Pharmacology and 61 papers in Molecular Biology. Recurrent topics in Bijo Mathew's work include Cholinesterase and Neurodegenerative Diseases (81 papers), Synthesis and biological activity (65 papers) and Computational Drug Discovery Methods (48 papers). Bijo Mathew is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (81 papers), Synthesis and biological activity (65 papers) and Computational Drug Discovery Methods (48 papers). Bijo Mathew collaborates with scholars based in India, Saudi Arabia and South Korea. Bijo Mathew's co-authors include Md. Sahab Uddin, Githa Elizabeth Mathew, Hoon Kim, Jerad Suresh, Md. Tanvir Kabir, Lotfi Aleya, Ghulam Md Ashraf, Della Grace Thomas Parambi, Gülberk Uçar and Seetha Harilal and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and The Journal of Physical Chemistry B.

In The Last Decade

Bijo Mathew

236 papers receiving 5.7k citations

Peers

Countries citing papers authored by Bijo Mathew

Since Specialization

Citations

This map shows the geographic impact of Bijo Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bijo Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bijo Mathew more than expected).

Fields of papers citing papers by Bijo Mathew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bijo Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bijo Mathew. The network helps show where Bijo Mathew may publish in the future.

Co-authorship network of co-authors of Bijo Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Bijo Mathew. A scholar is included among the top collaborators of Bijo Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bijo Mathew. Bijo Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of monoamine oxidase by fluorobenzyloxy chalcone derivatives 2025 ·RSC Advances ·(unknown), Jong‐Min Oh, Prabitha Prabhakaran, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Rasha Hamed Al‐Serwi, Hoon Kim, Bijo Mathew	0
2	Design, synthesis, in vitro, and in silico studies of novel isatin-hybrid hydrazones as potential triple-negative breast cancer agents 2025 ·RSC Advances ·Iqra Munir, (unknown), (unknown), Javid Hussain, (unknown), Suraj N. Mali, (unknown), Bijo Mathew, Tahani Mazyad Almutairi, Ahmed Al‐Harrasi, Muhammad Safwan Akram, Zahid Shafiq	6
3	Studies on N-(6-Indazolyl) benzenesulfonamide Derivatives as Potential Anticancer Agents: Integrating Synthesis, In silico Docking, and Molecular Dynamics Simulations 2024 ·Journal of Computational Biophysics and Chemistry ·(unknown), (unknown), Suraj N. Mali, Sunil Kumar, Bijo Mathew, Archana Kapoor	0
4	Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors 2024 ·RSC Advances ·(unknown), (unknown), Ajmal Khan, Suraj N. Mali, Sunil Kumar, Bijo Mathew, (unknown), (unknown), Gaber E. Eldesoky, Silvia Schenone, Ahmed Al‐Harrasi, Zahid Shafiq	6
5	Recent Progress in Synthetic and Natural Catechol-O-methyltransferase Inhibitors for Neurological Disorders 2024 ·ACS Omega ·(unknown), (unknown), Haya Yasin, (unknown), (unknown), Ankita Patel, Della Grace Thomas Parambi, Suraj N. Mali, T. M. Rangarajan, Bijo Mathew	2
6	A structure-based approach to explore novel COX-2 inhibitors using pharmacophore modelling, 3D-QSAR analysis, virtual screening and dynamics simulation study 2023 ·Journal of Molecular Structure ·(unknown), (unknown), Sunil Kumar, (unknown), (unknown), (unknown), T P Aneesh, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Orazio Nicolotti, (unknown), Bijo Mathew	7
7	In vitro and in vivo Antidiabetic Activity of Ag Nanoparticles Mediated from Gymnemic acid I and II 2023 ·Indian Journal of Pharmaceutical Education and Research ·(unknown), (unknown), Bijo Mathew, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
8	Urachal carcinoma: The journey so far and the road ahead 2023 ·Pathology - Research and Practice ·Rajesh Kumar, Seetha Harilal, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Arun Kumar, Bijo Mathew	9
9	Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation 2023 ·RSC Advances ·Sunil Kumar, (unknown), (unknown), Mohamed A. Abdelgawad, Wael A. Mahdi, Sultan Alshehri, Mohammed M. Ghoneim, (unknown), (unknown), T P Aneesh, Bijo Mathew	8
10	A Concise Review of the Recent Structural Explorations of Chromones as MAO-B Inhibitors: Update from 2017 to 2023 2023 ·Pharmaceuticals ·(unknown), Sunil Kumar, (unknown), (unknown), (unknown), (unknown), Ginson George, Prashant Gahtori, Hoon Kim, Bijo Mathew	8
11	Development of bromo- and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease 2022 ·Journal of Molecular Structure ·Mohamed A. Abdelgawad, Jong‐Min Oh, Della Grace Thomas Parambi, Sunil Kumar, Arafa Musa, Mohammed M. Ghoneim, AbdElAziz A. Nayl, Ahmed H. El‐Ghorab, Iqrar Ahmad, Harun Patel, Hoon Kim, Bijo Mathew	39
12	An Update of Synthetic Approaches and Structure‐Activity Relationships of Various Classes of Human MAO‐B Inhibitors 2021 ·ChemistrySelect ·Pratibha Sharma, Manjinder Singh, Bijo Mathew	14
13	Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders 2021 ·Pharmaceutics ·(unknown), Jong‐Min Oh, Ahmed Khames, Mohamed A. Abdelgawad, Aathira Sujathan Nair, Lekshmi R. Nath, Nicola Gambacorta, Fulvio Ciriaco, Orazio Nicolotti, Hoon Kim, Bijo Mathew	30
14	Synthesis of N′-(4-/3-/2-/Non-substituted benzylidene)-4-[(4-methylphenyl)sulfonyloxy] Benzohydrazides and Evaluation of Their Inhibitory Activities against Monoamine Oxidases and β-Secretase 2021 ·Applied Sciences ·(unknown), Jong‐Min Oh, (unknown), Sercan Yıldırım, (unknown), (unknown), Ahmed Khames, Mohamed A. Abdelgawad, Nicola Gambacorta, Orazio Nicolotti, Bijo Mathew, Hoon Kim	4
15	TV 3326 for Alzheimer’s dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer’s-like neuropathology 2020 ·Journal of Pharmacy and Pharmacology ·Md. Sahab Uddin, Md. Tanvir Kabir, M. M. Rahman, Bijo Mathew, Muhammad Ajmal Shah, Ghulam Md Ashraf	34
16	Identification of Indole‐Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO‐B Inhibitors 2016 ·Archiv der Pharmazie ·(unknown), S. L. Manju, Gülberk Uçar, İpek Baysal, Bijo Mathew	64
17	Isolation of chemical constituents from Spilanthes calva DC: Toxicity, anthelmintic efficacy and in silico studies 2014 ·Biomedicine & Preventive Nutrition ·(unknown), Bijo Mathew, Chitra Mani, R. Govindarajan	4
18	Design of 1-(furan-2-yl)-N-(5-substituted phenyl-1, 3, 4-thiadiazol-2-yl) methanimine derivatives as Enoyl-ACP reductase inhibitors: Synthesis, molecular docking studies and anti-tubercular activity 2013 ·SHILAP Revista de lepidopterología ·Bijo Mathew, Githa Elizabeth Mathew, (unknown), (unknown), (unknown), (unknown)	1
19	Anthelmintic activity of leaves of garcinia cambogia 2011 ·International Journal of Research in Pharmaceutical Sciences ·Githa Elizabeth Mathew, Bijo Mathew, (unknown), (unknown), (unknown)	4
20	Synthesis, characterisation of some 2-azetidinone derivatives from 2-aminopyridine and evaluation of their antimicrobial activity. 2010 ·Der pharma chemica ·Bijo Mathew, (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact